Beneficial effect of aggressive low-density lipoprotein apheresis in a familial hypercholesterolemic patient with severe diabetic scleredema.

Abstract

We present a 59-year-old woman with severe diabetic scleredema (DS) associated with heterozygous familial hypercholesterolemia (FH). She had been treated with drugs to lower blood glucose, with insulin for diabetes mellitus (DM), and with low-density lipoprotein (LDL) apheresis therapy monthly or every 2 weeks in addition to drugs to lower serum lipids for FH. However, her scleredema had not improved. After we had tried weekly LDL apheresis therapy for a period of 3 years to treat her hyperlipidemia, the levels of her serum lipids were reduced to normal ranges, and scleredema in her nape improved. We also demonstrated the histopathological improvement in dermis of her cervical skin. We conclude that weekly LDL apheresis therapy is effective for diabetic scleredema that is resistant to conventional treatments.

• Authors: N Koga
• Journal: Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis (Ther Apher) Vol. 5 Issue 6 Pg. 506-12 (Dec 2001) ISSN: 1091-6660 [Print] United States
• PMID: 11800090 (Publication Type: Case Reports, Journal Article)

Chemical References

• Lipoproteins, LDL

Topics

• Blood Component Removal
• Diabetes Complications
• Female
• Humans
• Hyperlipoproteinemia Type II (therapy)
• Lipoproteins, LDL (blood)
• Middle Aged
• Scleredema Adultorum (therapy)